The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Precipitating or Predisposing Factor? | Research Challenges | Patient Assessment | Alcohol | Drugs | Prevention and Treatment Recommendations | Conclusion | References

Excerpt

Substance use is a known risk factor for suicide attempts and death from suicide. In the United States, suicide is a leading cause of death among individuals with substance use disorders (SUDs; Substance Abuse and Mental Health Services Administration 2016). Between 43% and 65% of suicide attempts and completions are estimated to involve substance use (Steele et al. 2018). Internationally, SUDs are the second most common mental health disorder among suicide victims (Conner et al. 2014).

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).